U.S. Markets closed

S&P 500
3,811.15
-18.19(-0.48%)
Dow 30
30,932.37
-469.64(-1.50%)
Nasdaq
13,192.35
+72.92(+0.56%)

Cantel Medical Corp. (CMD)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

74.28+0.89 (+1.21%)

At close: 4:00PM EST

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	73.39
Open	74.01
Bid	74.22 x 1000
Ask	74.20 x 800
Day's Range	73.15 - 74.62
52 Week Range	20.81 - 89.10
Volume	434,670
Avg. Volume	528,291

Market Cap	3.139B
Beta (5Y Monthly)	1.56
PE Ratio (TTM)	98.25
EPS (TTM)	0.76
Earnings Date	Mar 09, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Jan 16, 2020
1y Target Est	73.50

All

Research Reports

PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CUB, COHR, CMD, FLIR, BPFH, AJRD
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2021
CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2021 on Tuesday, March 9, 2021 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
- Conference Call Notice: Intertape Polymer Group Inc. Fourth Quarter 2020 & Annual Results
  GlobeNewswire
- Great Ajax Corp. Schedules Its Fourth Quarter and Year End 2020 Financial Results Release for Thursday, March 4, 2021
  Business Wire
PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds LACQ, GWPH, PRSP, and CMD Shareholders About Its Ongoing Investigations
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
- Pandion Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Pandion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PAND
  Business Wire
- SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation
  GlobeNewswire